Back to Search
ROOMI NUSRAT, M.D.
M.D.
Pulmonary Disease Physician
NPI: 1275723306Individual
Specialties, Licenses & Credentials
Critical Care Medicine (Internal Medicine) Physician
Internal Medicine — Critical Care Medicine
Code: 207RC0200X
25MA08923100(NJ)4301116855(MI)
Infectious Disease Physician
Internal Medicine — Infectious Disease
Code: 207RI0200X
25MA08923100(NJ)4301116855(MI)
Pulmonary Disease PhysicianPrimary
Internal Medicine — Pulmonary Disease
Code: 207RP1001X
4301116855(MI)
Research & Publications (15)
Pakistani urban population demonstrates a poor knowledge about cancers: a pilot survey.
PMID 19058078·J Cancer Educ·2008
8-other
Awareness and use of Benzodiazepines in healthy volunteers and ambulatory patients visiting a tertiary care hospital: a cross sectional survey.
PMID 18350143·PLoS One·2008
8-other
Telithromycin in the treatment of pneumococcal community-acquired respiratory tract infections: a review.
PMID 16183318·Int J Infect Dis·2006
6-review
Clinical and bacteriologic efficacy of telithromycin in patients with bacteremic community-acquired pneumonia.
PMID 16376537·Respir Med·2006
1-meta
Pharmacodynamics of an 800-mg dose of telithromycin in patients with community-acquired pneumonia caused by extracellular pathogens.
PMID 15878442·Diagn Microbiol Infect Dis·2005
3-trial
Telithromycin for the treatment of acute exacerbations of chronic bronchitis.
PMID 15857326·Int J Clin Pract·2005
4-observational
Efficacy of telithromycin in community-acquired pneumonia caused by pneumococci with reduced susceptibility to penicillin and/or erythromycin.
PMID 15980629·Chemotherapy·2005
3-trial
Five-day telithromycin once daily is as effective as 10-day clarithromycin twice daily for the treatment of acute exacerbations of chronic bronchitis and is associated with reduced health-care resource utilization.
PMID 16236845·Chest·2005
3-trial
Efficacy of oral telithromycin in community-acquired pneumonia caused by resistant Streptococcus pneumoniae.
PMID 16230216·J Infect·2005
3-trial
Telithromycin for the treatment of acute bacterial maxillary sinusitis: a review of a new antibacterial agent.
PMID 16217977·South Med J·2005
1-meta
Efficacy of telithromycin in community-acquired pneumonia caused by Legionella pneumophila.
PMID 15322940·Eur J Clin Microbiol Infect Dis·2004
4-observational
Clinical and bacteriological efficacy and safety of 5 and 7 day regimens of telithromycin once daily compared with a 10 day regimen of clarithromycin twice daily in patients with mild to moderate community-acquired pneumonia.
PMID 15269191·J Antimicrob Chemother·2004
3-trial
Hospitalization rates among patients with community-acquired pneumonia treated with telithromycin vs clarithromycin: results from two randomized, double-blind, clinical trials.
PMID 15265241·Curr Med Res Opin·2004
3-trial
Activity of telithromycin against key pathogens associated with community-acquired respiratory tract infections.
PMID 15236918·J Infect·2004
8-other
Comparison of hospitalization rates in patients with community-acquired pneumonia treated with 10 days of telithromycin or clarithromycin.
PMID 15140342·Curr Med Res Opin·2004
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 7500 CHALLIS RD
BRIGHTON, MI 48116 - Phone
- (810) 263-4000
Quick Facts
- NPI
- 1275723306
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 5
- Locations
- 1
- Publications
- 15
Are you this provider?
Claim Your Profile